Howe & Rusling’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $328K | Sell |
5,409
-80
| -1% | -$4.66K | 0.02% | 226 |
|
|
2025
Q4 | $296K | Sell |
5,489
-99
| -2% | -$4.76K | 0.02% | 239 |
|
|
2025
Q3 | $252K | Sell |
5,588
-168
| -3% | -$7.85K | 0.02% | 259 |
|
|
2025
Q2 | $266K | Sell |
5,756
-2,372
| -29% | -$116K | 0.02% | 246 |
|
|
2025
Q1 | $496K | Hold |
8,128
| – | – | 0.04% | 162 |
|
|
2024
Q4 | $460K | Buy |
8,128
+467
| +6% | +$26.1K | 0.04% | 163 |
|
|
2024
Q3 | $396K | Sell |
7,661
-2,462
| -24% | -$115K | 0.03% | 185 |
|
|
2024
Q2 | $420K | Sell |
10,123
-451
| -4% | -$20.2K | 0.04% | 164 |
|
|
2024
Q1 | $573K | Sell |
10,574
-1,492
| -12% | -$76K | 0.05% | 137 |
|
|
2023
Q4 | $619K | Sell |
12,066
-1,598
| -12% | -$83.9K | 0.07% | 125 |
|
|
2023
Q3 | $793K | Sell |
13,664
-72,623
| -84% | -$4.45M | 0.09% | 114 |
|
|
2023
Q2 | $5.52M | Sell |
86,287
-20
| -0% | -$1.34K | 0.62% | 58 |
|
|
2023
Q1 | $5.98M | Sell |
86,307
-278
| -0.3% | -$19.6K | 0.71% | 48 |
|
|
2022
Q4 | $6.23M | Buy |
86,585
+35,668
| +70% | +$2.69M | 0.78% | 46 |
|
|
2022
Q3 | $3.62M | Sell |
50,917
-26,923
| -35% | -$1.95M | 0.48% | 61 |
|
|
2022
Q2 | $5.99M | Buy |
77,840
+1,194
| +2% | +$90.9K | 0.76% | 48 |
|
|
2022
Q1 | $5.6M | Buy |
76,646
+1,047
| +1% | +$70.3K | 0.65% | 55 |
|
|
2021
Q4 | $4.71M | Sell |
75,599
-29,356
| -28% | -$1.72M | 0.55% | 59 |
|
|
2021
Q3 | $6.21M | Sell |
104,955
-1,117
| -1% | -$73.6K | 0.78% | 47 |
|
|
2021
Q2 | $7.09M | Sell |
106,072
-26,375
| -20% | -$1.72M | 0.89% | 42 |
|
|
2021
Q1 | $8.36M | Sell |
132,447
-67,895
| -34% | -$4.22M | 1.14% | 30 |
|
|
2020
Q4 | $12.4M | Sell |
200,342
-689
| -0.3% | -$42.4K | 1.89% | 13 |
|
|
2020
Q3 | $12.1M | Sell |
201,031
-30,276
| -13% | -$1.82M | 2.08% | 10 |
|
|
2020
Q2 | $13.6M | Buy |
231,307
+26,316
| +13% | +$1.57M | 2.51% | 8 |
|
|
2020
Q1 | $11.4M | Buy |
204,991
+25,204
| +14% | +$1.54M | 2.46% | 7 |
|
|
2019
Q4 | $11.5M | Sell |
179,787
-76,763
| -30% | -$4.4M | 1.91% | 11 |
|
|
2019
Q3 | $13M | Buy |
256,550
+2,758
| +1% | +$130K | 2.28% | 8 |
|
|
2019
Q2 | $11.5M | Buy |
253,792
+145,228
| +134% | +$6.76M | 1.99% | 12 |
|
|
2019
Q1 | $5.18M | Buy |
108,564
+103,721
| +2,142% | +$5.17M | 0.9% | 38 |
|
|
2018
Q4 | $252K | Sell |
4,843
-435
| -8% | -$23.4K | 0.05% | 141 |
|
|
2018
Q3 | $328K | Buy |
5,278
+1,120
| +27% | +$66.5K | 0.05% | 123 |
|
|
2018
Q2 | $230K | Buy |
4,158
+566
| +16% | +$30.6K | 0.04% | 147 |
|
|
2018
Q1 | $227K | Sell |
3,592
-5,008
| -58% | -$322K | 0.04% | 159 |
|
|
2017
Q4 | $527K | Sell |
8,600
-487
| -5% | -$30.5K | 0.1% | 112 |
|
|
2017
Q3 | $579K | Buy |
9,087
+5,673
| +166% | +$331K | 0.11% | 106 |
|
|
2017
Q2 | $190K | Sell |
3,414
-593
| -15% | -$32.3K | 0.04% | 156 |
|
|
2017
Q1 | $218K | Sell |
4,007
-50,982
| -93% | -$2.8M | 0.04% | 141 |
|
|
2016
Q4 | $3.21M | Sell |
54,989
-16,645
| -23% | -$910K | 0.71% | 57 |
|
|
2016
Q3 | $3.86M | Sell |
71,634
-10,965
| -13% | -$704K | 0.83% | 55 |
|
|
2016
Q2 | $6.08M | Buy |
82,599
+180
| +0.2% | +$12.7K | 1.34% | 22 |
|
|
2016
Q1 | $5.26M | Buy |
82,419
+6,319
| +8% | +$398K | 1.19% | 36 |
|
|
2015
Q4 | $5.24M | Buy |
76,100
+71,399
| +1,519% | +$4.72M | 1.2% | 34 |
|
|
2015
Q3 | $278K | Hold |
4,701
| – | – | 0.07% | 128 |
|
|
2015
Q2 | $313K | Buy |
4,701
+231
| +5% | +$15.2K | 0.07% | 135 |
|
|
2015
Q1 | $288K | Sell |
4,470
-609
| -12% | -$38.1K | 0.06% | 139 |
|
|
2014
Q4 | $300K | Hold |
5,079
| – | – | 0.07% | 130 |
|
|
2014
Q3 | $260K | Buy |
+5,079
| New | +$254K | 0.06% | 136 |
|
|
2014
Q2 | – | Sell |
-8,096
| Closed | -$421K | – | 850 |
|
|
2014
Q1 | $421K | Buy |
8,096
+2,267
| +39% | +$121K | 0.1% | 108 |
|
|
2013
Q4 | $310K | Buy |
5,829
+1,808
| +45% | +$92.1K | 0.08% | 123 |
|
|
2013
Q3 | $186K | Sell |
4,021
-5,961
| -60% | -$262K | 0.07% | 140 |
|
|
2013
Q2 | $446K | Buy |
+9,982
| New | +$433K | 0.12% | 113 |
|
Other funds holding BMY
VCM
VPM
Howe & Rusling's BMY Position: Q1 2026 in Review
Howe & Rusling reduced its Bristol-Myers Squibb (BMY) stake by 1.5% in Q1 2026, selling an estimated $4.66K and leaving 5,409 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #226.
Howe & Rusling first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.6M in Q2 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Howe & Rusling held 5,409 shares of Bristol-Myers Squibb worth $328K as of Q1 2026.
- Howe & Rusling sold 80 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.66K.
- Bristol-Myers Squibb made up 0.02% of Howe & Rusling's portfolio in Q1 2026, its #226 holding.
- Howe & Rusling first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Howe & Rusling's Bristol-Myers Squibb position peaked at $13.6M in Q2 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.